Recent advances in understanding idiopathic pulmonary fibrosis [version 1; referees: 2 approved]
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dismal prognosis of idiopathic pulmonary fibrosis (IPF) remains unchanged. The elaboration of international diagnostic criteria and disease stratification models based on clinical, physiological, radiolo...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
F1000 Research Ltd
2016-05-01
|
| Series: | F1000Research |
| Assuntos: | |
| Acceso en liña: | http://f1000research.com/articles/5-1046/v1 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|